{
  "ticker": "CHRS",
  "success": true,
  "price": {
    "current": 2.33,
    "currency": "USD",
    "day_high": 2.39,
    "day_low": 2.08,
    "52_week_high": 2.616,
    "52_week_low": 0.71
  },
  "market_cap": {
    "value": 281629472.0,
    "currency": "USD"
  },
  "shares_outstanding": 120871013.0,
  "volume": {
    "last": 2239994,
    "average_30d": 3271261
  },
  "valuation": {
    "pe_ratio": 4.2363634,
    "forward_pe": -4.7551017,
    "price_to_book": 3.0860927
  },
  "company_info": {
    "name": "Coherus Oncology, Inc.",
    "sector": "Healthcare",
    "industry": "Biotechnology"
  },
  "balance_sheet": {
    "success": true,
    "period_date": "2025-09-30",
    "total_assets": 516519000.0,
    "total_liabilities": 428745000.0,
    "stockholders_equity": 87774000.0,
    "cash": 103352000.0,
    "marketable_securities": 88311000.0,
    "total_liquidity": 191663000.0,
    "total_debt": 40694000.0,
    "long_term_debt": 36957000.0,
    "current_debt": 1791000.0,
    "error": null
  },
  "cash_flow": {
    "success": true,
    "period_date": "2025-09-30",
    "operating_cash_flow": -46339000.0,
    "free_cash_flow": -46339000.0,
    "investing_cash_flow": -67227000.0,
    "financing_cash_flow": 2000.0,
    "error": null
  },
  "income_statement": {
    "success": true,
    "period_date": "2025-09-30",
    "operating_expense": 52183000.0,
    "research_and_development": 27252000.0,
    "interest_expense": 2325000.0,
    "net_income": -35531000.0,
    "revenue": 11571000.0,
    "gross_profit": 7850000.0,
    "ebitda": -41226000.0,
    "error": null
  },
  "data_quality": {
    "flags": [],
    "has_price": true,
    "has_market_cap": true,
    "has_volume": true,
    "has_balance_sheet": true,
    "has_cash_flow": true,
    "has_income_statement": true
  },
  "provenance": {
    "source": "Yahoo Finance via yfinance",
    "timestamp": "2026-01-29T16:44:58.689302",
    "url": "https://finance.yahoo.com/quote/CHRS",
    "data_hash": "5942d5bb4d5c5f8c"
  }
}